Undisclosed Biologic 2

About Microviable Therapeutics

Microviable Therapeutics is a private, preclinical-stage biotech focused on harnessing the microbiome to develop live biotherapeutic products (LBPs). The company's core assets are three biological drugs nearing clinical development, targeting oncology and infectious diseases with antibiotic resistance. Beyond its internal pipeline, Microviable offers a range of services including custom biotherapeutic development, microbiota analysis, and markets GutAlive®, an anaerobic microbiome collection kit designed for clinical and research applications. The company appears to be pre-revenue, building value through its platform and pipeline.

Therapeutic Areas